Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000417623 | SCV000522205 | likely benign | not specified | 2015-12-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000905927 | SCV001050533 | likely benign | Galactosylceramide beta-galactosidase deficiency | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001700177 | SCV004130227 | likely benign | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing | GALC: BP4, BP7 |
Prevention |
RCV003970154 | SCV004784323 | likely benign | GALC-related condition | 2019-08-28 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV001700177 | SCV001917350 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001700177 | SCV001966114 | likely benign | not provided | no assertion criteria provided | clinical testing |